Bank of America Corporation »

Allogene Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 331k 3.21
2023-09-30 $2.7M 837k 3.17
2023-06-30 $3.6M 716k 4.97
2023-03-31 $5.1M 1.0M 4.94
2022-12-31 $5.4M 865k 6.29
2022-06-30 $3.1M 268k 11.40
2021-12-31 $4.0M 270k 14.92
2021-06-30 $4.3M 163k 26.07
2021-03-31 $2.1M 59k 35.30
2020-12-31 $8.6M 339k 25.24
2020-09-30 $1.6M 43k 37.72
2020-06-30 $2.1M 49k 42.82
2020-03-31 $566k 29k 19.44
2019-12-31 $740k 29k 25.96
2019-09-30 $1.0M 38k 27.26
2019-03-31 $2.7M 95k 28.90
2018-12-31 $551k 20k 26.95